大麻 - Marijuana, Japanese Sacred Herb

- First and Only Grower Receiving Necessary Quota for Cultivation - 

NEWS PROVIDED BY PharmaCielo 8:10 ET

RIONEGRO, Colombia and TORONTO, Dec. 27, 2017 /PRNewswire/ -- PharmaCielo Colombia Holdings S.A.S. ("PharmaCielo Colombia"), the wholly owned subsidiary of Canadian medicinal cannabis firm PharmaCielo Ltd. ("PharmaCielo") today announced that it has begun the process of planting both psychoactive (THC) and non-psychoactive (CBD) medicinal cannabis strains at its Nursery and Propagation Centre in Rionegro.

"As the only grower to receive the necessary quota approval from the Colombian government, we are very excited to know that we will have our very first planting completed by December 31," said Federico Cock-Correa, CEO and Director of PharmaCielo Colombia. "We thank the government for their recognition of PharmaCielo's readiness for the immediate planting of a wide variety of exclusive and historically important Colombian cannabis strains, which have been utilized for spiritual and wellness purposes by Colombia's indigenous communities for decades and in some instances centuries."

The Nursery and Propagation Centre of PharmaCielo Colombia has a footprint of 27.7 hectares, with 12.1 hectares (1.3 million sq. feet) of open-air greenhouses dedicated to cultivation. As the initial planting matures, it will propagate additional plantings, with the expectation of the initial harvest occurring mid-year for processing and oil extraction. Over time, PharmaCielo will supply plant seedlings to over 1,000 hectares (2,500 acres) of contract growers' open-air greenhouses for final cultivation.

"We see a steady increase in interest from leading participants in today's rapidly developing global cannabis marketplace, seeking to develop strategic partnerships with PharmaCielo to access high volumes of premium quality medicinal-grade cannabis oil extracts and related products," added Dr. Patricio Stocker, President and CEO of PharmaCielo Ltd. "This is a very exciting time for the company, and we look forward to increasing our future cultivation footprint and quota as we ramp up production to meet global demand."

About PharmaCielo Ltd.

PharmaCielo Ltd. is a global company privately held and headquartered in Canada, with a focus on processing and supplying all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors. PharmaCielo's principal (and wholly-owned) subsidiary is PharmaCielo Colombia Holdings S.A.S., headquartered at its nursery and propagation centre located in Rionegro, Colombia. 

The boards of directors and executive teams of both PharmaCielo and PharmaCielo Colombia Holdings are comprised of a diversely talented group of international business executives and specialists with relevant and varied expertise. PharmaCielo recognized the significant role that Colombia's ideal location will play in building a sustainable business in the medical cannabis industry, and the company, together with its directors and executives, has built a compelling business plan focused on supplying the international marketplace.

For further information: 
www.PharmaCielo.com

Jim Rogers, who retired from the Quantum Fund, cofounded with George Soros, at age 37 and is well known for his insight into commodity markets, seems pretty bearish these days on almost everything, but one commodity he likes is cannabis, especially that which will be grown in Colombia. According to the New York Times, Rogers is an investor in PharmaCielo, a Canadian company we have featured several times over the past few months that is developing an export business in the Rionegro region. He also serves as an advisor. PharmaCielo, which has a production license but hasn’t yet received its cultivation license, expects its production costs to be as low as $0.05 per gram as it utilizes the equatorial sun in its greenhouses. In addition to PharmaCielo, Cannavida and Labfarve-Ecomedics have received production licenses. PharmaCielo is privately held but has closed multiple SEC-registered financing rounds over the past two years.

zzz

Once it receives approval, PharmaCielo will start growing marijuana and then process the material into medical products that can be exported to Canada and other countries that allow the importation of medical cannabis. The United States, for now, remains a long way off. “Ultimately, this has the ability to be a global marketplace measured in the billions,” said Anthony Wile, a Canadian venture capitalist who is one of PharmaCielo’s backers. Jim Rogers, a co-founder with George Soros of the Quantum Fund, is also an investor. Standing on a 32-acre plot of land that will be PharmaCielo’s initial site, Mr. Cock-Correa set out his case for why Colombia is ideal for marijuana production, centered on the country’s advantageous climate and soil conditions. There is a reason that Pablo Escobar got his start in the Colombian drug world by trafficking marijuana.

http://bit.ly/2cZLu8E